Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Shares Outstanding (Weighted Average): 2015-2025

Historic Shares Outstanding (Weighted Average) for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $100.6 million.

  • AC Immune's Shares Outstanding (Weighted Average) rose 1.09% to $100.6 million in Q3 2025 from the same period last year, while for Mar 2018 it was $57.4 million, marking a year-over-year increase of 1.02%. This contributed to the annual value of $100.6 million for FY2025, which is N/A change from last year.
  • According to the latest figures from Q3 2025, AC Immune's Shares Outstanding (Weighted Average) is $100.6 million, which was up 0.22% from $100.4 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Shares Outstanding (Weighted Average) peaked at $100.6 million during Q3 2025, and registered a low of $71.9 million during Q1 2021.
  • For the 3-year period, AC Immune's Shares Outstanding (Weighted Average) averaged around $94.2 million, with its median value being $99.4 million (2024).
  • Data for AC Immune's Shares Outstanding (Weighted Average) shows a peak YoY rose of 18.85% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows AC Immune's Shares Outstanding (Weighted Average) stood at $72.9 million in 2021, then rose by 15.88% to $84.5 million in 2022, then rose by 0.30% to $84.7 million in 2023, then climbed by 17.85% to $99.8 million in 2024, then grew by 1.09% to $100.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $100.6 million for Q3 2025, versus $100.4 million for Q2 2025 and $100.4 million for Q1 2025.